Bruker Corp at Jefferies London Healthcare Conference Transcript
All right. We'll go ahead and get started. Thanks, everybody, for being here. Welcome to the Jefferies 2022 London Healthcare Conference. I'm Brandon Couillard. I cover the tools and diagnostics space. It's my great pleasure to have Bruker with us back at the conference this year here to share an update on all their progress, CFO, Gerald Herman; as well as Justin Ward, Head of IR in the audience. I will turn it over to Gerald for some prepared remarks, and then we'll jump into Q&A. Gerald?
Well, thank you, Brandon, and it's great to be here. This is my third year, and it seems busier than ever, I would say, this year. So I thought we'd start just with a little bit of background on Bruker. I'll pass over the safe harbor materials that's -- my colleague usually reads those.
But just to give you a little bit of update on the performance, the financial performance of Bruker over the last 9 months. Some of you have been
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
